The limited polymorphism of HLA-E and lack of down-regulation during HIV infection makes the continued identification of Mtb-specific HLA-E antigens an attractive goal in developing novel vaccine candidates or diagnostic targets. This evidence concerns the gene HLA-E and HIV infectious disease.